SHEA GUIDELINES Bundle (free trial)

NICU Staphylococcus aureus

SHEA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1524008

Contents of this Issue

Navigation

Page 4 of 5

Interventions Decolonization ➤ Intranasal mupirocin twice daily for 5–7 days is an acceptable method for S. aureus decolonization of infants. However, the optimal decolonization method for infants has not been determined. ➤ Units: • Units should not use systemic antimicrobials as a decolonization strateg y. This approach has not been studied in this population and it may select for antibiotic-resistant organisms and lead to adverse drug events. • Choose to perform targeted S. aureus decolonization in specific situations to reduce the risk of infection in colonized infants — for example: (1) when an outbreak has been identified and (2) when a colonized patient may be at higher risk for infection (e.g., low birth weight, indwelling devices, or prior to high-risk surgeries). ➤ The effectiveness of universal decolonization (treating all infants regardless of S. aureus colonization status) as a strategy to prevent S. aureus infections in NICUs is not definitively known. Contact Precautions ➤ Maintain contact precautions for the duration of hospitalization for infants: • In high-risk groups likely to remain MRSA-colonized – for example, infants with invasive (endotracheal tube) or noninvasive (nasal prongs) ventilation, a tracheostomy, or a draining/open wound. • Who are MRSA-colonized, due to high rates of persistent and/or recurrent colonization. ➤ Units should: • Define criteria for removal of contact precautions. • Develop processes to document infants who have cleared MRSA through surveillance testing. • Perform serial surveillance testing to document continued clearance of MRSA colonization after contact precautions are removed. • Consider applying preemptive contact precautions for complex patients in outbreak settings or NICUs with ongoing MRSA transmission – for example, with central venous catheters, nonintact skin, or ventilator tubes, while admission S. aureus surveillance results are pending. Preemptive contact precautions may not be needed in non-outbreak settings and NICUs without ongoing MRSA transmission.

Articles in this issue

Archives of this issue

view archives of SHEA GUIDELINES Bundle (free trial) - NICU Staphylococcus aureus